Stockwinners Market Radar for July 14, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:37 EDT FTC loses appeal to block Activision takeover by Microsoft - A U.S. appeals court denied a Federal Trade Commission bid to pause Microsoft's (MSFT) acquisition of Activision Blizzard (ATVI). Microsoft President Brad Smith said via Twitter, "We appreciate the Ninth Circuit's swift response denying the FTC's motion to further delay the Activision deal. This brings us another step closer to the finish line in this marathon of global regulatory reviews." Shares of Activision are up 3% to $93.10 in after-hours trading.

17:23 EDT Seagen, Pfizer receive Second Request from FTC regarding merger - As previously disclosed, on March 12, 2023, Seagen (SGEN) entered into an Agreement and Plan of Merger by and among the company, Pfizer (PFE) and Aris Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pfizer. Pursuant to the Merger Agreement, Merger Sub will be merged with and into the company, with the company surviving the Merger as a wholly owned subsidiary of Pfizer. On July 14, 2023, the company and Pfizer each received a request for additional information and documentary materials from the Federal Trade Commission in connection with the FTC's review of the Merger. The effect of a Second Request is to extend the waiting period imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, until 30 days after the company and Pfizer each have substantially complied with the Second Request issued to it, unless that period is terminated sooner by the FTC. The parties expect to promptly respond to the Second Requests and to continue to work cooperatively with the FTC in its review of the Merger. Completion of the Merger remains subject to the expiration or termination of the waiting period under the HSR Act and the satisfaction or waiver of the other closing conditions specified in the Merger Agreement. In addition, as previously disclosed, on June 1, 2023, the Company and Pfizer referred the Merger to the European Commission (the "EC") for review under Article 4(5) of the EU Merger Regulation. On June 23, 2023, the EC accepted jurisdiction as a result of such referral and receipt of approval from the EC for the Merger has become a condition for the closing of the Merger. The Company continues to expect that the Merger will be completed in late 2023 or early 2024, subject to the fulfillment of customary closing conditions, including receipt of required regulatory approvals.

17:03 EDT Learn CW Investment extends business combination period to August 13 - Learn CW Investment announced that it has deposited into the company's trust account an aggregate of $115,000 to further extend the period of time the company has to consummate its initial business combination by an additional one month, from the current deadline of July 13, 2023 to August 13, 2023. This is the fourth of up to six one-month extensions permitted under the company's governing documents.

16:58 EDT Fat Projects Acquisition to extend deadline to complete business combination - Fat Projects Acquisition announced the deposit into the company's trust account of an aggregate of $24,279.65 representing $0.05 per share for each of its 485,593 outstanding publicly held Class A ordinary shares. The deposit enables the company to extend the period of time it has to consummate its initial business combination by one month from July 15, 2023 to August 15, 2023 . The Extension is the fourth of up to nine one-month extensions permitted under the company's governing documents. The funds came from the working capital of the company raised from non-interest-bearing loans from affiliates of the company's Sponsor, directors or officers.

16:41 EDT Trxade Health amends merger agreement with Superlatus - Trxade Health announced that it entered into an amended and restated merger agreement with Superlatus which amends the terms of the original merger agreement entered into by the parties on June 30, 2023. As restated, upon closing of the merger, shareholders of Superlatus will receive an aggregate of 30,821,941 shares of MEDS stock at $7.30 per share, which will be comprised of (i) 136,441 shares of MEDS common stock, representing 19.99% of the total issued and outstanding MEDS common stock at the closing of the merger, and (ii) 306,855 shares of a new class of MEDS non-voting convertible preferred stock with a conversion ratio of 100 to one, multiplied by such shareholder's pro rata percentage ownership. In addition, the amended and restated merger agreement provides that, effective one business day immediately prior to the closing date, TRxADE will issue to the shareholders of TRxADE as of the MEDS Rights Record Date, including the independent directors who are entitled to certain amount of MEDS common stock in connection with their 2023 annual compensation and regardless of whether the common stock has been issued or vest before the MEDS Rights Records Date, a non-transferrable right to receive one share of MEDS common stock at no cost, with seven MEDS Rights issued per share of common stock of TRxADE held as of the MEDS Rights Record Date.

16:32 EDT Lennar announces retirement of co-CEO, co-President Rick Beckwitt - Lennar announced that after 17 years with Lennar, Rick Beckwitt has decided to retire as a Co-CEO and Co-President and resign as a member of the Board of Directors of the company. Beckwitt's retirement will be effective September 1, 2023. With this change, Miller will continue as Executive Chairman and will additionally become Co-CEO to lead Lennar in partnership with Jaffe, Co-CEO and President.

16:21 EDT U.S. Silica appoints Koppers Holdings CFO to board, expands to eight members - U.S. Silica Holdings (SLCA) announced that it has appointed Jimmi Sue Smith to its board of directors effective July 14. The election of Smith increases the size of the company's board to eight members. Smith will also serve as an independent member of the Audit Committee of the Board. Smith has served as CFO of Koppers Holdings (KOP) since January 2022.

16:06 EDT Sixth Street expands board to 10 directors - The board of directors of Sixth Street announced that P. Emery Covington was appointed to the company's board of directors on July 10. Covington's appointment brings the total number of directors to 10, six of whom are not "interested persons" of the company as defined in Section 2(a)(19) of the Investment Company Act of 1940, as amended. Covington will serve on the Company's Board as a Class II director who is not an "interested person" until the date of the company's 2025 Annual Meeting of Stockholders or until her successor is duly elected and qualified. Also on July 10, Covington was appointed as a member of the Company's Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.

16:03 EDT Paramount parent National Amusements in talks with creditors, WSJ says - National Amusements, the family holding company of Shari Redstone, disclosed it is facing heightened financial risks is in negotiations with creditors to renegotiate some of its debt, The Wall Street Journal's Juliet Chung, Alexander Gladstone and Jessica Toonkel. The disclosure relates to a subsidiary of National Amusements that owns movie theaters, people familiar with the situation said. National Amusements holds nearly 80% of the voting stock in Paramount Global, as well as nonvoting Paramount shares, the report noted. Reference Link

16:00 EDT Baosheng Media Group Holdings Ltd trading resumes

15:47 EDT Baosheng Media Group Holdings Ltd trading halted, volatility trading pause

14:00 EDT Mallinckrodt Ord Shs trading resumes

13:33 EDT Mallinckrodt Ord Shs trading halted, news pending

13:01 EDT Baker Hughes reports U.S. rig count down 5 to 675 rigs

12:06 EDT Fisker terminates agreement to sell shares through JPMorgan, Cowen - Fisker disclosed that effective July 12, the company terminated its distribution agreement, dated May 24, 2022, by and among the company, J.P. Morgan Securities and Cowen and Company. The distribution agreement provided that Fisker may sell shares of its common stock from time to time for an aggregate offering price of up to $350M through an "at the market" equity offering program. As of July 12, approximately $23.4M remained available under the program. As a result of the termination of the distribution agreement, the company will not offer or sell any more shares under the program.

12:00 EDT Freedom Acquisition I falls -12.7% - Freedom Acquisition I is down -12.7%, or -$1.24 to $8.49.

12:00 EDT Redwire rises 7.6% - Redwire is up 7.6%, or 23c to $3.29.

12:00 EDT Elanco rises 11.6% - Elanco is up 11.6%, or $1.23 to $11.83.

11:26 EDT Citi: 'More work to do' in ECM, M&A

11:12 EDT Citi committed to returning capital to shareholders, says CEO

11:03 EDT Citi 'committed' to medium-term ROTCE target, says CEO

11:00 EDT Origin Agritech receives Nasdaq deficiency notice - Origin Agritech received a letter from the NASDAQ Stock Market notifying the Company that it currently did not meet the minimum market value of listed securities requirement of having a market value of listed securities equal to or greater than $35M. Therefore, the Company was not in compliance with the continued listing rules of NASDAQ set forth in the NASDAQ Listing Rules 5550(b)(2). The non-compliance period was from May 24, through July 7, 2023. According to the letter, the Company has until January 8, 2024 to achieve compliance with the market value requirement for continued listing. In the event the Company does not regain compliance with the rule prior to the expiration of the compliance period, it will receive additional written notification that its securities will be subject to delisting. At that time, the Company may appeal the delisting determination to a hearing panel. If at any time prior to January 8, 2024, the market value of the listed securities equals $35M or more for a minimum of ten consecutive business days, the Company will regain compliance with the particular continued listing requirement.

10:37 EDT Ciena, Sanmina lead communication equipment stocks lower - Ciena (CIEN) and Sanmina (SANM) are among the communication equipment stocks moving lower in morning trading. Others selling off are Juniper Networks (JNPR), Infinera (INFN), CommScope (COMM), Ribbon Communications (RBBN) and Viavi (VIAV).

10:20 EDT Wells Fargo expects staffing levels to further decline in 2H

10:13 EDT Wells Fargo expects to repurchase more stock this year

10:12 EDT State Street says Q2 results 'were below our potential' - Says balance sheet, liquidity remains strong. Says returned approx. $1.3B in capital in Q2. Says intends to continue common share repurchases. Says financial conditions in Q2 were mixed. Says focused on controlling expense base. Comments taken from Q2 earnings conference call.

10:09 EDT Wells Fargo: Likely be continued economic slowing - The range of scenarios could narrow over the next few quarters, the bank said.

10:05 EDT Wells Fargo: Regulatory pressure on banks continues to grow - Comments taken from Q2 earnings conference call.

10:00 EDT Vista Energy falls -9.9% - Vista Energy is down -9.9%, or -$2.70 to $24.69.

10:00 EDT Telus International falls -31.1% - Telus International is down -31.1%, or -$4.58 to $10.13.

10:00 EDT Elanco rises 6.9% - Elanco is up 6.9%, or 73c to $11.33.

09:47 EDT Vista Energy falls -8.0% - Vista Energy is down -8.0%, or -$2.18 to $25.21.

09:47 EDT Telus International falls -27.9% - Telus International is down -27.9%, or -$4.11 to $10.60.

09:47 EDT Glaukos rises 6.9% - Glaukos is up 6.9%, or $4.96 to $76.59.

09:45 EDT Canopy Growth sinks 27% to 47c after reaching agreements with lenders

09:37 EDT Western Acquisition Ventures Corp trading resumes

09:36 EDT EdtechX Holdings Acquisition Corp II trading resumes

09:33 EDT PainReform Ltd trading halted, volatility trading pause

09:31 EDT Deep Medicine Acquisition Corp trading halted, volatility trading pause

09:30 EDT Brilliant Acquisition Corp trading halted, volatility trading pause

09:27 EDT Hawkins completes acquisition of EcoTech - Hawkins has added its 40th Water Treatment location by completing the acquisition of EcoTech Enterprises. EcoTech manufactures, blends, packages and distributes water treatment chemicals for its customers throughout Arkansas and surrounding states.

09:21 EDT Chijet Motor's FAW Jilin completes first shipment of automobile orders to Peru - Chijet Motor Company's majority-owned subsidiary FAW Jilin Automobile has completed the first shipment of automobile orders to Peru through its newly developed export operation at Tianjin Port, China. This milestone marks the official opening of FAW Jilin's dual-channel export model, signifying a new phase of development for the Company's international marketing business. Previously, FAW Jilin relied on its minority shareholder, China FAW, for international trade. However, in response to dynamic Chinese market conditions, including intensified price competition in 2023, FAW Jilin established its own overseas market and export team alongside FAW Group's import and export company.

09:14 EDT WISeKey to develop picosatellite solution for quantum-ready IoT communications - WISeKey announced that its subsidiaries, SEALSQ and WISeSat joined forces to create an ultra-secure picosatellite solution for Quantum-Ready Internet of Things communications. The initiative will leverage the integration of the VaultIC408 secure element to secure each endpoint within the network, ensuring top-tier security levels throughout. Leveraging their advanced miniaturization techniques, the collaboration between both companies aims to provide solutions able to reduce costs and increase accessibility, so that businesses of all sizes can afford dedicated satellites to provide connectivity to their ecosystems. Seventeen WISeSat-ready satellites have already been launched into orbit with SpaceX as part of an 80-satellite constellation. These satellites are able to deliver global and real-time IoT connectivity for industrial applications, featuring a remarkable data latency of only 10 hours.

09:07 EDT JPMorgan expects NII run rate 'substantially lower' at some point - Says current NII run rate "not sustainable." Says "very confident" in company's ability to produce returns in current cycle. Says company has been "over-earning" on credit for a "substantial period." Says still some headwinds in M&A. Expects "reasonably robust" card loan growth. Says consumer "continues to surprise on the upside."

09:02 EDT Ace Global Business Acquisition announces contribution to trust account - Ace Global Business Acquisition announced that Ace Global Investment Limited, the company's initial public offering sponsor, has deposited into the company's trust account an aggregate of $116,777.35 representing, approximately $0.05 per ordinary share, in order to extend the period of time the company has to complete a business combination for an additional one month period, from August 9, 2023 to September 8, 2023. The company issued a promissory note to the Sponsor with a principal amount equal to the amount deposited. The promissory note bears no interest and is convertible into the company's units at a price of $10.00 per unit at the closing of a business combination by the company. The purpose of the extension is to provide time for the company to complete a business combination.

08:48 EDT JPMorgan says settlement process with FDIC for First Republic deal on schedule - Expects deal to close mid-2024. Says business and consumer spending "remains resilient." Says macro trading "substantially normalized" versus a year ago. Seeing "encouraging signs" in capital markets. Expects: FY23 NII ~$87B; FY23 adjusted expense ~$84.5B; FY23 card services NCO rate of ~2.60%. Comments taken from Q2 earnings conference call.

08:33 EDT Twin Vee PowerCats sees industry growth in saltwater catamaran segment - Twin Vee PowerCats announced the saltwater catamaran segment of the recreational marine industry continues to grow in the Northeast and Southeast United States since the segment experienced a record-breaking number of sales in 2021. Based on recent data received from Northeast and Southeast markets, sales of saltwater catamarans ranging in size from 24 to 40 feet in length have grown by approximately 7% from May 2022 to May 2023 compared to the previous rolling 12-month period.

08:31 EDT AgriFORCE, Berry People agree to extend closing date of acquisition - AgriFORCE Growing Systems announced that following the recent Binding LOI to acquire Berry People, the parties have mutually agreed to extend the closing date until the end of August 2023, in order to allow both parties more time to complete certain closing conditions, including finalization of the Berry People audit. AgriFORCE and Berry People remain fully committed to the transaction.

08:31 EDT National Retail Properties raises quarterly dividend 2.7% to 56.5c per share - The Board of Directors of NNN REIT announced a quarterly dividend of 56.5c per share payable August 15 to shareholders of record as of July 31. The 2.7% increase in the quarterly dividend marks NNN's 34th consecutive annual dividend increase. NNN is one of only three publicly traded REITs to have increased its annual dividend for 34 or more consecutive years.

08:08 EDT Gilead announces FDA approval of Veklury sNDA - Gilead Sciences announced that the FDA approved a supplemental new drug application, or sNDA, for the use of Veklury in COVID-19 patients with severe renal impairment, including those on dialysis. With this approval, Veklury is now the first and only approved antiviral COVID-19 treatment that can be used across all stages of renal disease. More than 1 in 7 people in the U.S. are estimated to have chronic kidney disease, or CKD, and are at increased risk of COVID-19 related morbidity and mortality. The U.S. approval comes on the heels of the European Commission decision to extend the approved use of Veklury to treat COVID-19 in people with severe renal impairment, including those on dialysis, which was adopted on June 26.

08:07 EDT Mullen announces transfer of 350 Class 1 EV vehicles to Mississippi plant - Mullen Automotive announces the transfer of Class 1 EV cargo van vehicles between its plants in Mishawaka, Indiana, and Tunica, Mississippi, for final assembly pursuant to customer orders. 2023 Class 1 vehicle manufacturing highlights include: Over 350 Class 1 vehicles in preparation to be transferred to Tunica for final assembly; In addition, 300 Class 1 vehicles scheduled to arrive in Tunica for final assembly for the remainder of 2023. "Exciting times as we are getting very close to delivering vehicles to awaiting customers, beginning in August 2023, which allows us to recognize continued revenue growth over the last six months of 2023," said David Michery, CEO and chairman of Mullen Automotive.

08:06 EDT Applied Digital onboards first major customer for cloud service - Applied Digital announced the successful onboarding of its previously-announced first major AI Cloud Services customer, Character.AI. The onboarding, which includes the activation of the first compute cluster for Character.AI, comes just two months after the Company signed its first major AI customer in May 2023. In conjunction, Applied Digital received the first prepayment of its 24-month, $180 million contract, and the services are expected to be fully in place by year-end. The Company will receive additional prepayments as servers are commissioned. "We are happy to support Character.AI with our first H100 deployment and look forward to supporting their trajectory toward immense growth within the AI market," said Applied Digital CEO and Chairman, Wes Cummins. "This milestone serves as a strong validation of Applied Digital's mission of providing cutting-edge solutions for key players in the AI field through our cloud service."

08:04 EDT BlackRock debuts first ETF models for Canadian financial advisors - BlackRock brings five new model portfolios constructed using exchange traded funds to Canada to further support Canadian advisors. The iShares Strategic Allocation ETF Models provide access to highly diversified portfolios of global stocks and bonds at low cost, leveraging the breadth of iShares ETFs. iShares ETF Models: iShares 20/80 Strategic Allocation ETF Model; iShares 40/60 Strategic Allocation ETF Model; iShares 60/40 Strategic Allocation ETF Model; iShares 80/20 Strategic Allocation ETF Model; iShares 100/0 Strategic Allocation ETF Model; These all-in-one, global multi-asset iShares ETF Models are available on select platforms today; the new models will be provided by BlackRock Asset Management Canada, an indirect wholly-owned subsidiary of BlackRock.

08:03 EDT State Street plans to increase quarterly dividend 10% to 69c per share - Says Q2 fee revenue up 2% mainly driven by higher Front office software and data revenue, Securities finance, and Other fee revenue associated with tax credit investment accounting change; Says NII up 18% primarily due to higher global interest rates, partially offset by lower deposit balances; Says Expenses up 5% primarily reflecting higher salaries and continued business investments, partially offset by lower transaction processing costs and continued productivity savings; Says Positive operating leverage of 0.4%pts; Says AUC/A of $39.6T at quarter-end; business yet to be installed of $2.4T at quarter-end; Says new servicing wins of $141B primarily reflecting strong sales in the Asset Owners, Official Institutions and Alternatives client segments; Says $1.2T of AUC/A onboarded in 2Q23 primarily from an Alpha mandate in the Asset Managers client segment; Says State Street Alpha continued to gain momentum, including expanded relationships for existing mandates: 3 Alpha clients went live in 2Q23, resulting in a total of 15 live clients to-date; Says SaaS client implementations and conversions increased ARR for Front office solutions to $281M, up 12%; Says AUM of $3.8T at quarter-end, with net inflows of $38B across all 3 business lines. Comments taken from Q2 earnings conference call presentation slides.

08:01 EDT Eli Lilly to acquire Versanis for up to $1.925B in cash - Eli Lilly and Company and Versanis Bio announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with semaglutide in adults who are overweight or obese. Combining incretins with bimagrumab has the potential to further reduce fat mass while preserving muscle mass and may lead to better outcomes for people living with obesity and obesity-related complications. Under the terms of the agreement, Versanis shareholders could receive up to $1.925B in cash, inclusive of an upfront payment and subsequent payments upon achievement of certain development and sales milestones. The transaction is subject to customary closing conditions. Lilly will determine the accounting treatment of this transaction as a business combination or an asset acquisition, including any related acquired in-process research and development charges, according to Generally Accepted Accounting Principles upon closing. This transaction will thereafter be reflected in Lilly's financial results and financial guidance.

07:33 EDT Zai Lab treats first patient in mainland China in Phase 3 FORTITUDE-101 study - Zai Lab (ZLAB) announced that the first patient has been treated in the mainland China portion of the global registrational, Phase 3 FORTITUDE-101 study for bemarituzumab, a potential first-in-class Fc-optimized monoclonal antibody that is designed to block fibroblast growth factors from binding and activating Fibroblast Growth Factor Receptor 2b, inhibiting several downstream pro-tumor signaling pathways and potentially slowing tumor proliferation. FORTITUDE-101 is a global trial of bemarituzumab in first-line gastric cancer sponsored by Amgen (AMGN). The FORTITUDE-101 study is a double-blind, placebo-controlled Phase 3 trial in patients with untreated, unresectable locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma not amenable to curative therapy. Adult patients with FGFR2b overexpression will be randomized to bemarituzumab plus chemotherapy, versus placebo plus chemotherapy.

07:17 EDT CureVac CSO Igor Splawski to step down - CureVac announced that Dr. Igor Splawski, CureVac's Chief Scientific Officer, will step down effective July 14, 2023 to return to early-stage research in the United States. During the search for a successor, CureVac's Chief Development Officer, Myriam Mendila, will head the advancement of CureVac's mRNA technology platform and its integration with the clinical development of novel mRNA vaccines and therapeutics.

07:05 EDT Barrick Gold receives shares of Cascadia Minerals pursuant to spinout - Barrick Gold (GOLD) announced that on July 12, 2023 it received 2,788,696 common shares of Cascadia Minerals as partial consideration for the acquisition by Hecla Mining Company (HL) of all of the common shares of ATAC Resources pursuant to the previously announced plan of arrangement among Hecla, Alexco Resource Corp. and ATAC. The Cascadia common shares owned by Barrick represent approximately 10.1% of Cascadia's issued and outstanding common shares. Prior to completion of the ATAC Arrangement and the spin-out of Cascadia pursuant to that transaction, Barrick owned 27,886,960 common shares of ATAC, but did not own any securities of Cascadia. Barrick is holding the common shares of Cascadia for investment purposes.

07:01 EDT Canadian Solar Chief Legal Officer, Jianyi Zhang, retires - Canadian Solar announced Jianyi Zhang's retirement as the company's Chief Legal Officer, Chief Compliance Officer and Corporate Secretary, effective immediately. During his seven years at Canadian Solar, Zhang championed business integrity and led our legal team to excellence in complex matters in Canadian Solar's markets. Zhang has been succeeded in his roles by Kah Locke Tham as Corporate Secretary, and Jeffrey Kalikow as Interim Chief Compliance Officer until a successor is appointed. Tham is currently also the company's Global Corporate Controller, and Kalikow is General Counsel of the company's wholly owned subsidiary, Recurrent Energy. The company has initiated an executive search process to evaluate candidates for the Chief Legal Officer's role.

06:56 EDT Asensus Surgical: U.S. hospital initiates Senhance Surgical System program - Asensus Surgical announced that a leading United States-based hospital, has initiated a Senhance Surgical System program for use within their pediatric surgery department. The initiation of the Senhance program marks an important milestone as this represents the first system to be exclusively utilized by pediatric surgeons at a United States-based hospital, showcasing Senhance's unique applicability for pediatric applications. The company expects to provide further information in the next 60 days

06:51 EDT JPMorgan reports Q2 ROE 20%, ROTCE 25%

06:48 EDT JPMorgan CEO: We reported another quarter of strong results - Jamie Dimon, Chairman and CEO, commented on the financial results: "We reported another quarter of strong results, generating net income of $13.3 billion and an ROTCE of 23% after excluding a net after-tax gain of $1.8 billion relating to the First Republic transaction, as well as discretionary after-tax investment securities losses of $0.7 billion. Even after the First Republic transaction, we maintained an extraordinarily strong CET1 capital ratio of 13.8% and had $1.4 trillion in cash and marketable securities. While we expect material capital changes with the finalization of Basel III and probable changes to come for bank liquidity, we will manage to any new requirements as we have demonstrated in the past; however, we caution that material regulatory changes would likely have real world consequences for markets and end users." Dimon continued: "Almost all of our lines of business saw continued growth in the quarter. In Consumer & Community Banking, new checking account production was very strong, while card loans were up 18%. In the Corporate & Investment Bank, Investment Banking fees remained challenged, although we gained market share YTD. In Commercial Banking, Payments revenue remained very strong and grew 79%. Finally, Asset & Wealth Management had record long-term inflows of $61 billion, with inflows across channels, regions, and asset classes." Dimon added: "The U.S. economy continues to be resilient. Consumer balance sheets remain healthy, and consumers are spending, albeit a little more slowly. Labor markets have softened somewhat, but job growth remains strong. That being said, there are still salient risks in the immediate view-many of which I have written about over the past year. Consumers are slowly using up their cash buffers, core inflation has been stubbornly high (increasing the risk that interest rates go higher, and stay higher for longer), quantitative tightening of this scale has never occurred, fiscal deficits are large, and the war in Ukraine continues, which in addition to the huge humanitarian crisis for Ukrainians, has large potential effects on geopolitics and the global economy. While we cannot predict with any certainty how these factors will play out, we are currently managing the Firm to reliably meet the needs of our customers and clients in all environments." Dimon concluded: "I want to welcome our new First Republic colleagues and thank all of our employees. They did an extraordinary job serving our new First Republic clients, and they worked around the clock to onboard an unprecedented number of new clients across all lines of business as a result of the recent banking turmoil. The efforts by our employees also enabled us to extend credit and raise $1.2 trillion in capital in the first half of 2023 for businesses, governments, and U.S. consumers."

06:32 EDT Centogene regains Nasdaq compliance - Centogene announced that it has received notifications from the Nasdaq Stock Market Listing Qualifications Department informing the company that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1) and with the minimum Market Value of Publicly Held Shares requirement for continued listing on the Nasdaq under Nasdaq Listing Rules 5450(b)(3)(C). As a result, Centogene is now compliant with all applicable Nasdaq listing standards, and Nasdaq considers these matters closed.

06:21 EDT BlackRock reports Q2 total net inflows $80B - In Q2: $80B of quarterly total net inflows reflect continued strength of broad-based platform with positive flows across client types and regions.

06:18 EDT BlackRock reports Q2 AUM $9.43T, up 11% y/y

05:33 EDT Competition and Markets Authority extends Microsoft, Activision review - The U.K.'s Competition and Markets Authority has decided to extend its review of Microsoft's (MSFT) acquisition of Activision Blizzard (ATVI) by six weeks "as it considers that there are special reasons to do so." The revised period will therefore end on August 29. Reference Link